Stock Screener App

Frei -

Installieren

0.9365

1.50% -0.0143

after-market

Handel nachbörslich: .93 -0.0065 -0.69%

Cognition Therapeutics Inc (CGTX)

Überblick Nachrichten Preisverlauf Financials Forum Prognose

Cognition Therapeutics Inc Aktie (CGTX) Neueste Nachrichten

H.C. Wainwright Maintains Cognition Therapeutics(CGTX.US) With Buy Rating, Maintains Target Price $3 - Moomoo

Cognition Therapeutics, Inc.Common Stock (Nasdaq:CGTX) Detailed Stock Data - The Chronicle-Journal

CGTX News | COGNITION THERAPEUTICS INC (NASDAQ:CGTX) - ChartMill

MU: Micron Technology Inc Latest Stock Price, Analysis, News and Trading Ideas - Stocktwits

FDA aligns with Cognition on pivotal DLB psychosis trial - scanx.trade

An Alzheimer's drug will be discussed Sept. 15 by Cognition Therapeutics - Stock Titan

CGTX Q2 2026 Earnings: Narrower-Than-Expected Loss Provides Positive Surprise, Shares SlipFinancial Health Score - dars.gov.et

Cognition Therapeutics Inc (CGTX) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey

Cognition (CGTX) Today: Moves 1.14% Lower to $0.98 for the Current Session; Technical Setup: the $0.93 to $1.03 Range Remains in Focus under the Current SnapshotIPO Entry Watch - vinanet.vn

Cognition (CGTX) Today: Moves 1.14% Lower to $0.98 for the Current Session; Technical Setup - dars.gov.et

Cognition (CGTX) Earnings Report: Reported EPS Tops Expectations; Market Reaction: Shares Move 0.22% Lower in the Latest ReadingPreliminary Results - vinanet.vn

Cognition Therapeutics Number of Employees 2026 | Employee Count & Headcount Data - Revelio Labs

Cognition (CGTX) Close in Focus: Ends Down by 3.33% at $0.99; Chart Reference: Price Remains Between $0.94 Support and $1.04 Resistance in the Current UpdateOpening Range Breakout - careplusvn.com

HC Wainwright Has Bullish Estimate for CGTX Q3 Earnings - MarketBeat

Cognition Therapeutics (CGTX) Slips 2.9% to $1.01, Nears Support at $0.96Dealer Delta - vinanet.vn

Cognition Therapeutics (NASDAQ:CGTX) Stock Rating Lowered by Wall Street Zen - MarketBeat

CGTX FY2026 EPS Forecast Raised by Brookline Capital Markets - MarketBeat

Cognition Therapeutics Inc (CGTX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey

Cognition Therapeutics Inc (CGTX) Stock News Today - TradingKey

Cognition Therapeutics Stock (CGTX) Opinions on biotech upside speculation - Quiver Quantitative

Cognition Therapeutics (NASDAQ:CGTX) Releases Earnings Results, Beats Estimates By $0.02 EPS - MarketBeat

Cognition Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com

Cognition Therapeutics, Inc. (CGTX) latest stock news and headlines - Yahoo Finance UK

Cognition Therapeutics Inc Q2 2026: Net loss $(3.9M), EPS $(0.04) — 10-Q Summary - TradingView

Cognition Therapeutics Inc reports results for the quarter ended June 30Earnings Summary - TradingView

Cognition Therapeutics Q2 EPS beats estimate as R&D cuts narrow losses - scanx.trade

Cognition Therapeutics, Inc. (CGTX) Reports Q2 Loss, Lags Revenue Estimates - Yahoo Finance

Cognition Therapeutics reports Q2 2026 net loss $3.9M, cash $34.8M; plans Phase 3 in DLB psychosis - TradingView

Cognition Therapeutics Q2 net loss narrows on lower R&D costs - TradingView

Cognition Therapeutics Reports Financial Results for the Second Quarter 2026 and Provides Business Update - Yahoo Finance

Cognition Therapeutics Inc expected to post a loss of 6 cents a shareEarnings Preview - TradingView

Cognition Therapeutics (CGTX) Edges Higher as Traders Eye Key Resistance LevelsBearish Sentiment - careplusvn.com

Cognition Therapeutics (NASDAQ:CGTX) Trading Up 3.3%Time to Buy? - MarketBeat

Cognition Therapeutics Inc (CGTX) Balance Sheet - TradingKey

CGTX|Cognition Therapeutics Inc|Price:1.020|Chg%:-0.040 - tradingkey.com

Cognition Therapeutics Inc (CGTX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey

Cognition Therapeutics Inc (CGTX) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey

Cognition Therapeutics Inc (CGTX) Cash Flow - TradingKey

Cognition Therapeutics Inc (CGTX) Valuation: PE, PB & Fair Value Analysis - TradingKey

Cognition Therapeutics Inc (CGTX) Financial Health: Profitability & Balance Sheet Analysis - TradingKey

CGTX|Cognition Therapeutics Inc|Price:0.919|Chg%:-0.041 - TradingKey

Cognition Therapeutics Inc (CGTX) Income Statement - TradingKey

Cognition Therapeutics, Inc. Revenue Breakdown – NASDAQ:CGTX - TradingView

CGTX|Cognition Therapeutics Inc|Price:0.982|Chg%:-0.038 - TradingKey

CGTX Q1 2026 Earnings: Narrower-Than-Expected Loss Signals Progress in Alzheimer’s PipelineLong-Term Guidance - dars.gov.et

Cognition Therapeutics (CGTX) Slips 4% as Support Level Comes Into FocusBreakout Confirmation - dars.gov.et

Cognition Therapeutics (CGTX) Q2 2024 earnings summary - Quartr

CGTX Q1 2026 Earnings: Narrower Loss Bolsters Cash Runway as Alzheimer’s Trials ContinueGuidance Revision Trend - dars.gov.et

CGTX Q1 2026 Earnings: Narrower-than-expected loss as clinical pipeline advancesEarnings Power Value - careplusvn.com

Cognition Therapeutics (CGTX) Edges Higher as Biotech Stock Tests Key ResistanceAnalyst Upgrade Stocks - dars.gov.et

Is Cognition Therapeutics (NASDAQ:CGTX) In A Good Position To Invest In Growth? - Sahm

Cognition Therapeutics (CGTX) Edges Lower as Stock Hovers Near Key Support LevelRVOL Breakout - dars.gov.et

RANI Stock Price and Chart — NASDAQ:RANI - TradingView

Cognition Therapeutics CEO Lisa Ricciardi to Participate in B. Riley Mind, Muscle & Vision Summit Fireside Discussion - Quiver Quantitative

Alzheimer’s drug developer to outline Lewy body dementia Phase 3 plan - Stock Titan

Cognition Therapeutics Participating in Fireside Chat at B. Riley Securities' Mind, Muscle & Vision Summit - Yahoo Finance

Enterprise value to EBIT forward of Cognition Therapeutics, Inc. – NASDAQ:CGTX - TradingView

Can AI automation provide a survival tool amid managed care's thin margins? (CVS:NYSE) - Seeking Alpha

Enterprise value to revenue forward of Cognition Therapeutics, Inc. – NASDAQ:CGTX - TradingView

Number of shareholders of Cognition Therapeutics, Inc. – NASDAQ:CGTX - TradingView

Price to sales forward of Cognition Therapeutics, Inc. – NASDAQ:CGTX - TradingView

Price to earnings forward of Cognition Therapeutics, Inc. – NASDAQ:CGTX - TradingView

Analysts Are Bullish on These Healthcare Stocks: Pacira Pharmaceuticals (PCRX), Akebia Therapeutics (AKBA) - The Globe and Mail

Cognition Therapeutics, Inc. Financial Disclosures & SEC Filings - TradingView

H.C. Wainwright reiterates Cognition Therapeutics stock rating on FDA alignment - Investing.com South Africa

INSM

$117.83

3.06%

ROIV

$35.80

0.91%

RPRX

$58.21

0.14%

ALNY

$255.96

2.55%

ONC

$360.85

0.24%

RVMD

$204.97

2.56%

In Yahoo öffnen | In Google öffnen | In Finviz öffnen | In MarketWatch öffnen | Öffnen Sie in EDGAR | Offen in Reuters